Viracta Therapeutics (OTC:VIRX) 주식

Viracta Therapeutics

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.

benzinga_deal_dispatch2

Asset Sales

Legal

AMPS

BABA

BIGGQ

COEP

CPNG

VIRX

파산 블록 모든 것을 축하할 수 있는 원스톱 상점인 파티 시티 홀드코(Party City Holdco Inc.)가 사업 정리를 하고 있다. 회사 내 700개 매장에서 폐업 세일을 진행하고 있다.

딜 디스패치: 파티 시티 사업 정리, 빅랏츠 파산, 더 컨테이너 스토어 계속 영업 등

Wall Street

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

AREN

CSTM

EVAX

GDYN

GEAR

금요일(27일) 아침 미국 주식 선물이 하락하고 있는 가운데, 오늘 투자자들의 주목을 받을 수 있는 몇 가지 주식은 다음과 같다. 콘스텔리움, 비락타 테라퓨틱스, 에바종 바이오테크, 아레나 및 그리드 다이나믹

금요일 주목해야 할 주식: 콘스텔리움, 비락타, 에바종 바이오테크, 아레나 및 그리드 다이나믹

VIRACTA THERAPEUTICS INC by Viracta Therapeutics, Inc.

Viracta Therapeutics Inc

In 2017, the vice chairman of Berkshire Hathaway and Warren <a href="https://www.benzinga.com/personal-finance/24/12/42686059/warren-and-i-arent-prodigies-charlie-munger-said-knowing-what-you-dont-know-is-more-useful-than-being-brilliant">Buffett's</a><a href="https://www.benzinga.com/personal-finance/24/12/42686059/warren-and-i-arent-prodigies-charlie-munger-said-knowing-what-you-dont-know-is-more-useful-than-being-brilliant"> longtime business partner</a>, Charlie Munger, visited the Ross School of Business at the University of Michigan. He was interviewed by Dean Scott DeRue, sharing insights into his and the company's phenomenal success. His key message: long-term business success stems from thinking like an owner, not a corporate climber.
What Happened: Munger recalled how Buffett, in the early stages of his career, followed <a href="https://www.benzinga.com/general/entertainment/24/05/39080466/5-investment-lessons-from-benjamin-grahams-book-the-intelligent-investor-which-warren-buffe">Ben Graham's approach</a> of buying companies simply because they were undervalued, even if they were doomed.
Eventually, they abandoned that model in favor of acquiring high-quality businesses with lasting advantages. The turning point, Munger explained, was a change in mindset. "A lot of people running the businesses think like careerists," he said. "<a href="https://www.benzinga.com/news/25/02/43903504/charlie-mungers-financial-success-and-longevity-advice-my-game-in-life-was-always-to-avoid-all-standard-ways-of-failing">My advice to you</a> is you never want to be a careerist so much that you don&#8217;t see it from the owner&#8217;s point of view." Reflecting on their journey, he added, "We thought like capitalists, because we were always in the shareholder mindset."
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="A Conversation with Charlie Munger and Michigan Ross - 2017" width="500" height="281" src="https://www.youtube.com/embed/S9HgIGzOENA?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
See Also: <a href="https://www.benzinga.com/real-estate/25/06/46000636/warren-buffetts-real-estate-business-sounds-alarm-overpriced-homes-need-reductions">Warren Buffett&#8217;s Real Estate Business Sounds Alarm: &#8216;Overpriced&#8217; Homes Need Reductions</a>
Why It Matters: Munger pointed to General Motors as a cautionary tale. "The mightiest company in the world went bankrupt," he said.
"They had a bunch of careerists, and an owner would have seen immediately that situation was hopeless. And they just romped through it with a lot of denials and stupidity and pomposity, and of course they went bankrupt," Munger noted.
Munger was referring to what was then the <a href="https://www.forbes.com/sites/danbigman/2013/10/30/how-general-motors-was-really-saved-the-untold-true-story-of-the-most-important-bankruptcy-in-u-s-history/">largest bankruptcy in history</a>, when, on <a href="https://www.benzinga.com/markets/18/06/11814018/this-day-in-market-history-general-motors-declares-bankruptcy">June 1, 2009</a>, General Motors filed for bankruptcy in New York, listing $82 billion in assets and $173 billion in liabilities.
"None of those hotshot executives thought like an owner, or they would have seen that it was hopeless," Munger reiterated.
Read Next: <a href="https://www.benzinga.com/real-estate/25/06/45995200/when-the-skies-rain-gold-warren-buffett-says-to-carry-a-washtub-heres-where-its-pouring-right-now">When The Skies &#8216;Rain Gold&#8217; Warren Buffett Says To Carry A Washtub – Here&#8217;s Where It&#8217;s Pouring Right Now</a>
Image Via Shutterstock

Charlie Munger Called This The Biggest Leadership Mistake—It's More Common Than You Think: 'The Mightiest Company In The World Went Bankrupt'

TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) has outperformed the market over the past 15 years by 3.99% on an annualized basis producing an average annual return of 16.08%. Currently, TD Synnex has a market capitalization of $10.37 billion. 
Buying $1000 In SNX: If an investor had bought $1000 of SNX stock 15 years ago, it would be worth $9,799.09 today based on a price of $124.64 for SNX at the time of writing.
<h3>TD Synnex's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750344311_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In TD Synnex 15 Years Ago Would Be Worth Today

Macro Economic Events

Econ #s

Economics

Ruters Citing Iran's Atomic Energy Organization Says Aeli Attack On The Khondab Heavy Water Facility Caused No Casualties, No Threat Or Harm To Residents' In The Vicinity Of The Site

The Swiss National Bank cut its benchmark interest rate by 25 basis points to 0% on Thursday, marking the lowest level since 2022 and amplifying the gap between U.S. and Swiss <a href="https://www.benzinga.com/topic/interest-rates">rates to record highs</a>.
The move pushes the gap between the U.S. federal funds rate upper bound and Switzerland's rate to 4.5 percentage points—the largest differential on record.
<h3 class="wp-block-heading">What It Means For The Economy</h3>
The SNB said its decision was influenced by declining inflationary pressure and a deteriorating global economic outlook.
"In its baseline scenario, the SNB anticipates that growth in the global economy will weaken over the coming quarters," the central bank said. While it sees inflation in the U.S. rising, further declines are expected in Europe.
The SNB also warned that risks remain tilted to the downside, citing potential trade tensions and uncertainty around fiscal policy.
The Swiss rate cut means businesses and households in Switzerland now face the lowest borrowing costs among developed nations. 
Lower interest rates could also translate into increased demand by homebuyers and a weaker currency that benefits exporters. 
The yield on the 10-year Swiss government bond is just 0.3%, effectively allowing the Swiss government to borrow at almost no cost. 
In comparison, the U.S. 10-year Treasury yield stands at 4.40%, creating a spread of 4.1%, just shy of the record 4.3% gap seen in December 2024.
According to Goldman Sachs economist Sven Jari Stehn, the SNB will deliver another 25-basis-point cut to a terminal rate of negative 0.25% in September on the basis of the weaker growth and inflation.
<h3 class="wp-block-heading">Fed Holds Rates, Inflation Forecasts Climb</h3>
A day before the SNB&#8217;s decision, the Federal Reserve held interest rates steady at 4.25%-4.50%, with Chair Jerome Powell saying the central bank remains cautious about cutting too soon. 
The Fed's updated projections now see core PCE inflation at 3.1% in 2025, up from March's 2.8% forecast, and 2.5% by December.
Despite progress on inflation, Powell said the Fed is not yet confident enough to begin easing. Its dot plot still forecasts two rate cuts in 2025, consistent with March, and two in 2026—down from three previously projected.
<h3 class="wp-block-heading">Trump Pressures Fed: &#8216;We&#8217;d Be Saving Trillions&#8217;</h3>
President Donald Trump reignited his feud with Powell on Wednesday, calling for a more aggressive rate-cutting cycle. 
"We have almost no inflation. We have only success. I'd like to see interest rates get down now," Trump said, adding that just a one-point cut could deliver major relief for U.S. debt servicing costs.
According to Trump, the Fed should cut interest rates between 2 and 2.5 percentage points. 
Slashing rates would lead to massive savings on the debt refinancing front: "We'd be saving $700 billion, $800 billion—trillions over time," he said. 
Read now: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/market-summary/25/06/46010350/as-trump-weighs-options-on-iran-dow-futures-slip-defense-stocks-tick-up-in-after-hours-session">As Trump Weighs Options On Iran — Dow Futures Slip, Defense Stocks Tick Up In After-Hours Session </a></li>
</ul>
Image: Shutterstock/lunopark

Eurozone

Switzerland Interest Rate Reaches 0%, Gap With Fed Funds Soars To Historic Levels

Marsh &amp; McLennan Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 15 years by 3.87% on an annualized basis producing an average annual return of 15.96%. Currently, Marsh &amp; McLennan Cos has a market capitalization of $105.60 billion. 
Buying $100 In MMC: If an investor had bought $100 of MMC stock 15 years ago, it would be worth $935.49 today based on a price of $214.32 for MMC at the time of writing.
<h3>Marsh &amp; McLennan Cos's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750343415_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Marsh & McLennan Cos 15 Years Ago Would Be Worth Today

<a href="https://www.nidoliving.com/en-gb/blog/nido-living-acquires-livensa-living-portfolio">https://www.nidoliving.com/en-gb/blog/nido-living-acquires-livensa-living-portfolio</a>
&nbsp;

Brookfield To Sell Livensa Living To Nido Living For €1.2 Billion

McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) has outperformed the market over the past 20 years by 3.99% on an annualized basis producing an average annual return of 12.34%. Currently, McDonald's has a market capitalization of $207.19 billion. 
Buying $1000 In MCD: If an investor had bought $1000 of MCD stock 20 years ago, it would be worth $10,285.16 today based on a price of $289.99 for MCD at the time of writing.
<h3>McDonald's's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750342512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In McDonald's 20 Years Ago Would Be Worth This Much Today

<a href="https://truthsocial.com/@realDonaldTrump/posts/114710405985383754" title="https://truthsocial.com/@realDonaldTrump/posts/114710405985383754">https://truthsocial.com/@realDonaldTrump/posts/114710405985383754</a>

Federal Reserve

President Trump Posts On Truth Social ""Too Late" Jerome Powell is costing our Country Hundreds of Billions of Dollars. He is truly one of the dumbest, and most destructive, people in Government, and the Fed Board is complicit. Europe has had 10 cuts, we have had none. We should be 2.5 Points lower, and save $BILLIONS on all of Biden's Short Term Debt. We have LOW inflation! TOO LATE's an American Disgrace!"

Investor Steve Eisman has a surprising take on the escalating tensions in the Middle East, one that cuts from conventional wisdom during periods of geopolitical conflicts. 
What Happened: On Wednesday, Eisman said the crisis in Iran may actually turn out to be &#8220;extremely positive&#8221; for global markets and geopolitical stability during his appearance on CNBC&#8217;s &#8220;Squawk Box.&#8221;
The investor, best known for shorting collateralized debt obligations in the lead up to the 2008 financial crisis, which inspired the character played by Steve Carell in the 2015 movie &#8220;The Big Short,&#8221; describes Iran as a &#8220;death cult,&#8221; which is now &#8220;very close to getting a nuclear weapon.&#8221;
See Also: <a href="https://www.benzinga.com/markets/treasuries/25/06/46012056/peter-schiff-predicts-worse-financial-crisis-than-2008-as-fed-holds-rates-the-solution-involves-much-higher-interest-rates-as-years-of-easy-money-trigger-stagflation-and-investor-exodus">Peter Schiff Predicts &#8216;Worse Financial Crisis Than 2008&#8217; As Fed Holds Rates: &#8216;The Solution Involves Much Higher Interest Rates&#8217; As Years of Easy Money Trigger Stagflation And Investor Exodus</a>
Eisman argues that if Iran succeeds in its nuclear quest, it will trigger a regional arms race, with neighbors like Turkey and Saudi Arabia seeking their own deterrents. &#8220;That would have been a disaster,&#8221; he says, adding that getting rid of such a death cult anywhere in the world, &#8220;is a very positive thing.&#8221;
He also states that the markets hadn&#8217;t priced in this risk, but he believes the situation now offers potential upside, referring to the removal of a long-term geopolitical destabilizer that could benefit both the markets and global security.
Why It Matters: Stocks have been relatively unfazed since the beginning of this conflict, with limited impact on the benchmarks thus far. 
Economists, too, have recently stated that the impact on the U.S. economy from this conflict <a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45943707/us-economy-to-face-pretty-limited-impact-from-israel-iran-airstrikes-with-only-a-tiny-bit-recession-risk-say-economists">is fairly limited</a>. David Seif, Chief Economist&nbsp;for developed markets at&nbsp;Nomura, said, &#8220;recession&nbsp;risks are higher, but only&nbsp;by a tiny bit.&#8221;
The Chief Economist at&nbsp;Santander U.S. Capital Markets, Stephen Stanley, shared similar sentiments, that &#8220;the fallout to the U.S. is&nbsp;pretty limited.&#8221;
There are, however, several beneficiaries of this conflict, which primarily include defense companies that have been rallying over the past week. 
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Stocks</th>
<th class="has-text-align-center" data-align="center">Month-To-Date (%)</th>
<th class="has-text-align-center" data-align="center">Year-To-Date (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kratos Defense &amp; Security Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>)</td>
<td class="has-text-align-center" data-align="center">20.01</td>
<td class="has-text-align-center" data-align="center">59.82</td>
</tr>
<tr>
<td>Optex Systems Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPXS#NASDAQ">OPXS</a>)</td>
<td class="has-text-align-center" data-align="center">21.37</td>
<td class="has-text-align-center" data-align="center">50.87</td>
</tr>
<tr>
<td>BWX Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>)</td>
<td class="has-text-align-center" data-align="center">27.77</td>
<td class="has-text-align-center" data-align="center">26.06</td>
</tr>
<tr>
<td>RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>)</td>
<td class="has-text-align-center" data-align="center">6.32</td>
<td class="has-text-align-center" data-align="center">25.74</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Defense stocks have been rallying over the past month, amid intensifying tensions in the Middle East, and growing speculations regarding American involvement.</figcaption></figure>
Higher energy prices, however, can weigh on the economy, with Warren Patterson, head of commodity strategy at ING, saying that &#8220;Iran is a meaningful oil producer, pumping 3.3 million barrels per day and exporting around 1.7 million,&#8221; and any disruption in this, he says, can <a href="https://www.benzinga.com/markets/commodities/25/06/45924154/the-120-oil-shock-just-became-a-real-risk-are-we-back-in-2022">push prices to $120</a> per barrel.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="148" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/19050035/Screenshot-2025-06-19-at-2.30.24-PM-1024x148.png" alt="" class="wp-image-954947" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/19050035/Screenshot-2025-06-19-at-2.30.24-PM-1024x148.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/19050035/Screenshot-2025-06-19-at-2.30.24-PM-300x43.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/19050035/Screenshot-2025-06-19-at-2.30.24-PM-768x111.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/19050035/Screenshot-2025-06-19-at-2.30.24-PM.png 1526w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Kratos Defense &amp; Security Solutions scores remarkably well, across the board in Benzinga&#8217;s Edge Stock Rankings, with a favorable price trend in the short, medium, and long terms. Click <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a> for finer details on the stock and how it compares with peers and competitors. 
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="&#039;Big Short&#039; trader Steve Eisman: Iran conflict could potentially be &#039;extremely positive&#039; for markets" width="500" height="281" src="https://www.youtube.com/embed/OmcvuRRXgE4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/46012244/obama-warns-america-is-dangerously-close-to-autocracy-calls-for-civic-resistance-im-still-the-hope-guy">Obama Warns America Is &#8216;Dangerously Close&#8217; To Autocracy, Calls For Civic Resistance: &#8216;I&#8217;m Still The Hope Guy&#8217;</a></li>
</ul>
Image Via Shutterstock

Equities

BWXT

KTOS

OPXS

'The Big Short' Investor Steve Eisman Says Iran Crisis Could Be 'Extremely Positive' For Markets, Calls Regime A 'Death Cult' Close To Nuclear Weapons

FOX Expands its Sports Broadcasting Footprint in Mexico with the Acquisition of a&nbsp;Market Leading Streaming Channel and Sports Rights Catalog
LOS ANGELES, June 19, 2025 /PRNewswire/ --&nbsp;Fox Corporation ("FOX" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>, FOX))) today announced its acquisition of Caliente TV, a leading sports broadcasting platform in Mexico. Carlos Martinez, a longtime industry executive, has been appointed to the role of Executive Vice President and Managing Director, Latin America, Fox Corporation, responsible for overseeing the overall FOX broadcast strategy in&nbsp;Latin America and the transition of Caliente TV&nbsp;in Mexico and the channel's launch in Central America.

FOXA

FOX Acquires Mexico's Caliente TV To Expand Sports Broadcasting Presence In Latin America; No Financial Terms Disclosed

Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) will release its quarterly earnings report on Friday, 2025-06-20. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Darden Restaurants to report an earnings per share (EPS) of $2.96.
Investors in Darden Restaurants are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.01, leading to a 0.46% increase in the share price on the subsequent day.
Here's a look at Darden Restaurants's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2025</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.79</td>
<td>2.02</td>
<td>1.83</td>
<td>2.61</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.80</td>
<td>2.03</td>
<td>1.75</td>
<td>2.65</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>2.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1750341645_0.png" alt="eps graph" />
<h3>Performance of Darden Restaurants Shares</h3>
Shares of Darden Restaurants were trading at $224.78 as of June 17. Over the last 52-week period, shares are up 45.32%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Insights Shared by Analysts on Darden Restaurants</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Darden Restaurants.
A total of 25 analyst ratings have been received for Darden Restaurants, with the consensus rating being Neutral. The average one-year price target stands at $220.84, suggesting a potential 1.75% downside.
<h3>Understanding Analyst Ratings Among Peers</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Texas Roadhouse, Aramark and Dutch Bros, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Texas Roadhouse, with an average 1-year price target of $185.73, suggesting a potential 17.37% downside.</li>
<li>Analysts currently favor an Buy trajectory for Aramark, with an average 1-year price target of $43.25, suggesting a potential 80.76% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Dutch Bros, with an average 1-year price target of $78.21, suggesting a potential 65.21% downside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
The peer analysis summary provides a snapshot of key metrics for Texas Roadhouse, Aramark and Dutch Bros, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Darden Restaurants</td>
<td>Neutral</td>
<td>6.16%</td>
<td>$702.30M</td>
<td>15.13%</td>
</tr>
<tr>
<td>Texas Roadhouse</td>
<td>Neutral</td>
<td>9.57%</td>
<td>$246.59M</td>
<td>8.30%</td>
</tr>
<tr>
<td>Aramark</td>
<td>Buy</td>
<td>1.89%</td>
<td>$359.64M</td>
<td>2.03%</td>
</tr>
<tr>
<td>Dutch Bros</td>
<td>Outperform</td>
<td>29.10%</td>
<td>$89.99M</td>
<td>2.70%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Darden Restaurants ranks in the middle for revenue growth among its peers. It is at the top for gross profit. For return on equity, it is also in the middle.
<h3>Discovering Darden Restaurants: A Closer Look</h3>
Darden Restaurants is the largest restaurant operator in the US full-service space, with consolidated revenue of $11.4 billion in fiscal 2024 resulting in 3%-4% full-service market share (per NRA data and our calculations). The company maintains a portfolio of 11 restaurant brands: Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Ruth's Chris, Yard House, The Capital Grille, Seasons 52, Eddie V's, Bahama Breeze, The Capital Burger, and most recently, Chuy's. Darden generates revenue almost exclusively from company-owned restaurants, though a small network of franchised restaurants and consumer-packaged goods sales through the traditional grocery channel contribute modestly. As of the end of its fiscal 2024, the company operated 2,031 restaurants in the US.
<h3>Darden Restaurants: Delving into Financials</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Darden Restaurants's remarkable performance in 3 months is evident. As of 28 February, 2025, the company achieved an impressive revenue growth rate of 6.16%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Darden Restaurants's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 10.24%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 15.13%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Darden Restaurants's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.58% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Darden Restaurants's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 2.76.
<a href="https://www.benzinga.com/quote/DRI/earnings">To track all earnings releases for Darden Restaurants visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

What to Expect from Darden Restaurants's Earnings

CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) is gearing up to announce its quarterly earnings on Friday, 2025-06-20. Here's a quick overview of what investors should know before the release.
Analysts are estimating that CarMax will report an earnings per share (EPS) of $1.17.
Anticipation surrounds CarMax's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Overview of Past Earnings</h3>
The company's EPS missed by $0.02 in the last quarter, leading to a 2.87% increase in the share price on the following day.
Here's a look at CarMax's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2025</th>
<th>Q3 2025</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.66</td>
<td>0.61</td>
<td>0.86</td>
<td>0.94</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.64</td>
<td>0.81</td>
<td>0.85</td>
<td>0.97</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>0.0%</td>
<td>-1.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1750341636_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of CarMax were trading at $64.43 as of June 17. Over the last 52-week period, shares are down 10.19%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Analyst Opinions on CarMax</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding CarMax.
A total of 11 analyst ratings have been received for CarMax, with the consensus rating being Outperform. The average one-year price target stands at $87.36, suggesting a potential 35.59% upside.
<h3>Analyzing Ratings Among Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Penske Automotive Group, Lithia Motors and Murphy USA, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Penske Automotive Group, with an average 1-year price target of $167.5, suggesting a potential 159.97% upside.</li>
<li>Analysts currently favor an Buy trajectory for Lithia Motors, with an average 1-year price target of $361.71, suggesting a potential 461.4% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Murphy USA, with an average 1-year price target of $516.67, suggesting a potential 701.91% upside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
The peer analysis summary presents essential metrics for Penske Automotive Group, Lithia Motors and Murphy USA, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>CarMax</td>
<td>Outperform</td>
<td>6.69%</td>
<td>$667.89M</td>
<td>1.44%</td>
</tr>
<tr>
<td>Penske Automotive Group</td>
<td>Buy</td>
<td>2.10%</td>
<td>$1.27B</td>
<td>4.61%</td>
</tr>
<tr>
<td>Lithia Motors</td>
<td>Buy</td>
<td>7.20%</td>
<td>$1.41B</td>
<td>3.12%</td>
</tr>
<tr>
<td>Murphy USA</td>
<td>Outperform</td>
<td>-6.57%</td>
<td>$483.60M</td>
<td>6.82%</td>
</tr>
</tbody>
</table>

Key Takeaway:
CarMax ranks first in revenue growth among its peers. It has the highest gross profit margin. CarMax has the lowest return on equity compared to its peers.
<h3>About CarMax</h3>
CarMax sells, finances, and services used and new cars through a chain of around 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 83% of fiscal 2025 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2025, the company retailed and wholesaled 789,050 and 544,312 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in calendar 2024. It seeks over 5% share. CarMax is based in Richmond, Virginia.
<h3>Key Indicators: CarMax's Financial Health</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Over the 3 months period, CarMax showcased positive performance, achieving a revenue growth rate of 6.69% as of 28 February, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 1.5%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): CarMax's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.44% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): CarMax's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.33% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: CarMax's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 3.08.
<a href="https://www.benzinga.com/quote/KMX/earnings">To track all earnings releases for CarMax visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What's Next: CarMax's Earnings Preview

SharpLink Gaming's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NYSE">SBET</a>) short percent of float has risen 2024.52% since its last report. The company recently reported that it has 434 thousand shares sold short, which is 65.86% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>SharpLink Gaming Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750341627_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for SharpLink Gaming has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing SharpLink Gaming's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, SharpLink Gaming's peer group average for short interest as a percentage of float is 5.38%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

SBET

How Do Investors Really Feel About SharpLink Gaming?

Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) is preparing to release its quarterly earnings on Friday, 2025-06-20. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Accenture to report an earnings per share (EPS) of $3.32.
Anticipation surrounds Accenture's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat EPS by $0.01, which was followed by a 1.47% increase in the share price the next day.
Here's a look at Accenture's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.81</td>
<td>3.42</td>
<td>2.78</td>
<td>3.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.82</td>
<td>3.59</td>
<td>2.79</td>
<td>3.13</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-2.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1750341626_0.png" alt="eps graph" />
<h3>Market Performance of Accenture's Stock</h3>
Shares of Accenture were trading at $312.03 as of June 17. Over the last 52-week period, shares are down 0.84%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analyst Insights on Accenture</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Accenture.
Accenture has received a total of 9 ratings from analysts, with the consensus rating as Outperform. With an average one-year price target of $375.44, the consensus suggests a potential 20.32% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of IBM, Infosys and Cognizant Tech Solns, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for IBM, with an average 1-year price target of $271.0, suggesting a potential 13.15% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Infosys, with an average 1-year price target of $17.5, suggesting a potential 94.39% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Cognizant Tech Solns, with an average 1-year price target of $85.55, suggesting a potential 72.58% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
The peer analysis summary provides a snapshot of key metrics for IBM, Infosys and Cognizant Tech Solns, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Accenture</td>
<td>Outperform</td>
<td>5.44%</td>
<td>$4.97B</td>
<td>6.12%</td>
</tr>
<tr>
<td>IBM</td>
<td>Outperform</td>
<td>0.55%</td>
<td>$8.03B</td>
<td>3.89%</td>
</tr>
<tr>
<td>Infosys</td>
<td>Neutral</td>
<td>-4.23%</td>
<td>$1.50B</td>
<td>7.56%</td>
</tr>
<tr>
<td>Cognizant Tech Solns</td>
<td>Neutral</td>
<td>7.46%</td>
<td>$1.72B</td>
<td>4.52%</td>
</tr>
</tbody>
</table>

Key Takeaway:
In terms of consensus rating, Accenture is rated higher than its peers. Accenture has the highest revenue growth among its peers. Accenture also leads in gross profit. However, in terms of return on equity, Accenture is not the highest among its peers.
<h3>Discovering Accenture: A Closer Look</h3>
Accenture is a leading global IT services firm that provides consulting, strategy, and technology and operational services. These services run the gamut from aiding enterprises with digital transformation to procurement services to software system integration. The company provides its IT offerings to a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture employs just under 500,000 people throughout 200 cities in 51 countries.
<h3>Accenture's Financial Performance</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Accenture displayed positive results in 3 months. As of 28 February, 2025, the company achieved a solid revenue growth rate of approximately 5.44%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Accenture's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.73% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Accenture's ROE stands out, surpassing industry averages. With an impressive ROE of 6.12%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Accenture's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.99% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Accenture's debt-to-equity ratio is below the industry average at 0.28, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/ACN/earnings">To track all earnings releases for Accenture visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Accenture's Earnings Outlook

Insmed's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NYSE">INSM</a>) short percent of float has risen 5.99% since its last report. The company recently reported that it has 17.46 million shares sold short, which is 10.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.27 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Insmed Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750341623_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Insmed has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Insmed's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Insmed's peer group average for short interest as a percentage of float is 6.63%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

INSM

What Does the Market Think About Insmed?

Novo Nordisk's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) short percent of float has risen 21.95% since its last report. The company recently reported that it has 33.67 million shares sold short, which is 1.0% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.28 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Novo Nordisk Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750341618_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Novo Nordisk has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Novo Nordisk's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Novo Nordisk's peer group average for short interest as a percentage of float is 4.03%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Do Investors Really Feel About Novo Nordisk?

In the current market session, Bain Capital Specialty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCSF#NYSE">BCSF</a>) price is at $14.98, after a 0.67% spike. However, over the past month, the stock decreased by 1.64%, and in the past year, by 8.44%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1750341617_0.png" alt="Past Year Chart" />

<h3>Bain Capital Specialty P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 22.26 in the Capital Markets industry, Bain Capital Specialty Inc. has a lower P/E ratio of 8.55. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1750341617_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

BCSF

P/E Ratio Insights for Bain Capital Specialty

Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) is preparing to release its quarterly earnings on Friday, 2025-06-20. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Kroger to report an earnings per share (EPS) of $1.46.
Investors in Kroger are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings History Snapshot</h3>
Last quarter the company beat EPS by $0.03, which was followed by a 4.58% increase in the share price the next day.
Here's a look at Kroger's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.11</td>
<td>0.98</td>
<td>0.91</td>
<td>1.34</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.14</td>
<td>0.98</td>
<td>0.93</td>
<td>1.43</td>
</tr>
<tr>
<td>Price Change %</td>
<td>5.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1750341615_0.png" alt="eps graph" />
<h3>Performance of Kroger Shares</h3>
Shares of Kroger were trading at $65.95 as of June 17. Over the last 52-week period, shares are up 30.49%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analysts' Take on Kroger</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Kroger.
Analysts have provided Kroger with 5 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $74.8, suggesting a potential 13.42% upside.
<h3>Comparing Ratings with Competitors</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Casey's General Stores, Sprouts Farmers Market and Albertsons Companies, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Casey's General Stores, with an average 1-year price target of $500.71, suggesting a potential 659.23% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Sprouts Farmers Market, with an average 1-year price target of $177.6, suggesting a potential 169.29% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Albertsons Companies, with an average 1-year price target of $24.89, suggesting a potential 62.26% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
The peer analysis summary outlines pivotal metrics for Casey's General Stores, Sprouts Farmers Market and Albertsons Companies, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kroger</td>
<td>Outperform</td>
<td>-7.44%</td>
<td>$7.92B</td>
<td>5.80%</td>
</tr>
<tr>
<td>Casey's General Stores</td>
<td>Outperform</td>
<td>2.28%</td>
<td>$912.57M</td>
<td>2.84%</td>
</tr>
<tr>
<td>Sprouts Farmers Market</td>
<td>Neutral</td>
<td>18.72%</td>
<td>$886.36M</td>
<td>13.80%</td>
</tr>
<tr>
<td>Albertsons Companies</td>
<td>Outperform</td>
<td>2.51%</td>
<td>$5.15B</td>
<td>5.09%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Kroger ranks at the bottom for Revenue Growth among its peers. It also has the lowest Gross Profit margin. However, Kroger's Return on Equity is higher than one of its peers. Overall, Kroger's performance is mixed compared to its peers in the analysis.
<h3>About Kroger</h3>
Kroger is one of the largest grocery retailers in the United States with more than 2,700 stores across a portfolio of over 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The company also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.
<h3>A Deep Dive into Kroger's Financials</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Negative Revenue Trend: Examining Kroger's financials over 3 months reveals challenges. As of 31 January, 2025, the company experienced a decline of approximately -7.44% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Kroger's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.79% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 5.8%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Kroger's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.07%, the company showcases efficient use of assets and strong financial health.
Debt Management: Kroger's debt-to-equity ratio stands notably higher than the industry average, reaching 3.03. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<a href="https://www.benzinga.com/quote/KR/earnings">To track all earnings releases for Kroger visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: Kroger's Earnings Preview

SLM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLM#NASDAQ">SLM</a>) has outperformed the market over the past 5 years by 19.94% on an annualized basis producing an average annual return of 33.81%. Currently, SLM has a market capitalization of $6.65 billion. 
Buying $1000 In SLM: If an investor had bought $1000 of SLM stock 5 years ago, it would be worth $4,204.24 today based on a price of $31.70 for SLM at the time of writing.
<h3>SLM's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750341613_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Politics

Global

General

iShares MSCI Israel Capped Investable Market Index Fund

Reuters Cites Iranian Diplomat Saying Iran's Bushehr Nuclear Power Plant Was Not Hit By Israel, Dismisses Israeli Claims As 'Psychological Warfare'

Press Releases

Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan

Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Viracta Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

Comments

Viracta Therapeutics

뉴스

파트너 / 기고자

벤징가 글로벌